According to the updated data in TCGA, BRCA1 and BRCA2 were non-synonymously mutated in 42 and 33 ovarian cancer cases, respectively, accounting for 12.9% and 10.1% of 325 patients (Table S1). The gene discussed is BRCA2; the disease is ovarian cancer.